Cargando…
Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
BACKGROUND: Multiple sclerosis (MS) is a chronic immune mediated disease and the progressive phase appears to have significant neurodegenerative mechanisms. The classification of the course of progressive MS (PMS) has been re-organized into categories of active vs. not active inflammatory disease an...
Autores principales: | Ciampi, Ethel, Uribe-San-Martin, Reinaldo, Cárcamo, Claudia, Cruz, Juan Pablo, Reyes, Ana, Reyes, Diego, Pinto, Carmen, Vásquez, Macarena, Burgos, Rafael A., Hancke, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203851/ https://www.ncbi.nlm.nih.gov/pubmed/32380977 http://dx.doi.org/10.1186/s12883-020-01745-w |
Ejemplares similares
-
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile
por: Ciampi, Ethel, et al.
Publicado: (2020) -
Frontoparietal connectivity correlates with working memory performance in multiple sclerosis
por: Figueroa-Vargas, Alejandra, et al.
Publicado: (2020) -
Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
por: Bertoglio, J. C., et al.
Publicado: (2016) -
Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
por: Arellano, Gabriel, et al.
Publicado: (2017) -
Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism
por: Burgos, Rafael Agustín, et al.
Publicado: (2020)